Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

Jan 9 : Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.Integration of Lilly's TuneLab into Schrodinger's LiveDesign will give biotech companies direct access to the artificial intelligence platform to

Eli Lilly Taps Chai Discovery’s Frontier AI to Design ‘Computer-Aided’ Biologics

What You Should Know – Eli Lilly and Company has entered a strategic collaboration with Chai Discovery to deploy frontier AI for the design of novel biologic therapeutics. – The partnership includes the development of an exclusive, purpose-built AI model trained on Lilly’s proprietary data, leveraging Chai’s Chai-2 platform to compress discovery timelines from months to weeks. The “Zero-Shot” Revolution: Slashing Discovery Timelines In the world…

Exclusive: With new AI deal, Eli Lilly and Chai Discovery kick off a 'year of deployment' in pharma

Eli Lilly has signed one of the pharma industry's largest AI software deals with Chai Discovery, a hard-charging startup that makes drug-designing AI models. While the companies aren't publicly disclosing financial details, Lilly will pay ...